ANAPTYSBIO, INC. (ANAB) Operating margin 2017–2026
ANAPTYSBIO, INC. (ANAB) operating margin by fiscal year — reported operating income divided by reported revenue.
96.7%FY2026 · since FY2017: -18.1% → 96.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 96.7% | +24.2 pp |
| FY2025 | 72.5% | +1030.7 pp |
| FY2024 | -958.3% | +161.1 pp |
| FY2023 | -1119.4% | -1029.5 pp |
| FY2022 | -89.9% | -58.1 pp |
| FY2021 | -31.8% | +1311.1 pp |
| FY2020 | -1342.9% | -8.5 pp |
| FY2019 | -1334.4% | -1046.6 pp |
| FY2018 | -287.8% | -269.7 pp |
| FY2017 | -18.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANAB financial trends
ANAB RevenueANAB Net incomeANAB Net marginANAB Gross profitANAB Gross marginANAB Operating incomeANAB Operating cash flowANAB Free cash flowANAB Capital expendituresANAB Return on equityANAB Stock buybacksANAB Dividends paidANAB Total assetsANAB Total liabilitiesANAB Shareholders’ equityANAB overview →